Vigalife Biopharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
About Vigalife Biopharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ganesh Nikam and Jaanhavi Nikam serve as directors at the Company.
- CIN/LLPIN
U85100PN2019PTC184988
- Company No.
184988
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jun 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vigalife Biopharma Private Limited offer?
Vigalife Biopharma Private Limited offers a wide range of products and services, including Survey Solution, Mapping Service, Freight Forwarding Services, International Courier Services, Aptitude Assessments, Talent Management Services.
Who are the key members and board of directors at Vigalife Biopharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganesh Nikam  | Director | 21-Jun-2019 | Current |
| Jaanhavi Nikam | Additional Director | 15-Feb-2023 | Current |
Financial Performance of Vigalife Biopharma.
Vigalife Biopharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vigalife Biopharma?
Unlock access to Vigalife Biopharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Medulla Recruitment Services Private LimitedActive 14 years 9 monthsGanesh Nikam and Jaanhavi Nikam are mutual person
Neosky Partners Limited Liability Partne RshipActive 10 years 2 monthsGanesh Nikam is a mutual person
- Emerging Star Management Consulting LlpActive 8 years 8 months
Ganesh Nikam and Jaanhavi Nikam are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vigalife Biopharma?
Unlock and access historical data on people associated with Vigalife Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vigalife Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vigalife Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
